These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22727178)

  • 1. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting.
    Bandeali SJ; Kayani WT; Lee VV; Pan W; Elayda MA; Nambi V; Jneid HM; Alam M; Wilson JM; Birnbaum Y; Ballantyne CM; Virani SS
    Am J Cardiol; 2012 Oct; 110(7):919-23. PubMed ID: 22727178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
    Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
    Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting.
    Johnston K; Stephens S
    Ann Pharmacother; 2012 Sep; 46(9):1239-44. PubMed ID: 22947592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery.
    Ouzounian M; Buth KJ; Valeeva L; Morton CC; Hassan A; Ali IS
    Ann Thorac Surg; 2012 Feb; 93(2):559-64. PubMed ID: 22269723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery.
    Kalavrouziotis D; Buth KJ; Cox JL; Baskett RJ
    Am Heart J; 2011 Nov; 162(5):836-43. PubMed ID: 22093199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between preoperative renal dysfunction and cardiovascular events (stroke, myocardial infarction, or heart failure or death) within three months of isolated coronary artery bypass grafting.
    Holzmann MJ; Sartipy U
    Am J Cardiol; 2013 Nov; 112(9):1342-6. PubMed ID: 23870631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
    Pan W; Pintar T; Anton J; Lee VV; Vaughn WK; Collard CD
    Circulation; 2004 Sep; 110(11 Suppl 1):II45-9. PubMed ID: 15364837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting.
    Miceli A; Capoun R; Fino C; Narayan P; Bryan AJ; Angelini GD; Caputo M
    J Am Coll Cardiol; 2009 Nov; 54(19):1778-84. PubMed ID: 19682819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
    Miceli A; Fino C; Fiorani B; Yeatman M; Narayan P; Angelini GD; Caputo M
    Ann Thorac Surg; 2009 Jun; 87(6):1853-8. PubMed ID: 19463608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery.
    Virani SS; Nambi V; Razavi M; Lee VV; Elayda M; Wilson JM; Ballantyne CM
    Am Heart J; 2008 Mar; 155(3):541-6. PubMed ID: 18294494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency.
    Tolpin DA; Collard CD; Lee VV; Elayda MA; Pan W
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):873-9. PubMed ID: 19660351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of preoperative neurologic events on outcomes after coronary artery bypass grafting.
    Halkos ME; Puskas JD; Lattouf OM; Kilgo P; Guyton RA; Thourani VH
    Ann Thorac Surg; 2008 Aug; 86(2):504-10; discussion 510. PubMed ID: 18640324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease.
    Sharony R; Grossi EA; Saunders PC; Galloway AC; Applebaum R; Ribakove GH; Culliford AT; Kanchuger M; Kronzon I; Colvin SB
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):406-13. PubMed ID: 14762348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.
    Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft.
    El-Chami MF; Kilgo P; Thourani V; Lattouf OM; Delurgio DB; Guyton RA; Leon AR; Puskas JD
    J Am Coll Cardiol; 2010 Mar; 55(13):1370-6. PubMed ID: 20338499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes.
    Singh SM; Goodman SG; Yan RT; Dery JP; Wong GC; Gallo R; Grondin FR; Lai K; Lopez-Sendon J; Fox KA; Yan AT;
    Am J Cardiol; 2012 Feb; 109(3):332-6. PubMed ID: 22078966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of preoperative angiotensin-converting enzyme inhibitor on the outcome of coronary artery bypass graft surgery.
    Zhang Y; Ma L
    Eur J Cardiothorac Surg; 2015 May; 47(5):788-95. PubMed ID: 25079771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
    Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
    Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.